Company Filing History:
1 out of 1,274 
1 out of 2,896 
Years Active: 2025
Title: The Innovative Contributions of Hannah Reid Hudson
Introduction
Hannah Reid Hudson is a prominent inventor based in Durham, NC (US). She has made significant strides in the field of cancer treatment through her innovative research and development of chimeric antigen receptors.
Latest Patents
Hannah Reid Hudson holds a patent for "Methods and compositions for chimeric antigen receptor targeting cancer cells." This invention provides a chimeric antigen receptor (CAR) that recognizes CSPG4, along with methods of use in the treatment of various diseases and disorders. Her work is pivotal in advancing therapeutic options for cancer patients.
Career Highlights
Throughout her career, Hannah has been associated with esteemed institutions such as the University of North Carolina at Chapel Hill and The General Hospital Corporation. Her contributions to research and development in the medical field have been recognized and valued.
Collaborations
Hannah has collaborated with notable professionals in her field, including Gianpietro Dotti and Soldano Ferrone. These partnerships have further enhanced her research and the impact of her inventions.
Conclusion
Hannah Reid Hudson's innovative work in developing chimeric antigen receptors represents a significant advancement in cancer treatment. Her dedication to research and collaboration continues to inspire progress in the medical community.